Middle Molecule Find

Rulebook › V-tags › V378

V378 Reprocessing method: manufacturer's or validated alternate

Written V0378 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.50(b)(2)(i) and (b)(2)(ii) · Appendix H Rev. 246, page 184 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.50(b)(2) - Reprocess hemodialyzers and bloodlines – (i) By following manufacturer’s recommendations; or (ii) Using an alternate method and maintaining documented evidence that the method is safe and effective.

Appendix H quotes this text a little differently from the regulation as published today. The eCFR has the current wording.

Read 42 CFR 494.50 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.50(b)(2)

Each manufacturer of dialyzers for multiple use is required by FDA to provide at least one acceptable reprocessing method with at least one germicide. The facility may use that method/germicide or choose an alternate method. If the facility has chosen an alternate method, there must be documentation that the chosen method has been validated as safe and effective.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 184 (the full 469-page PDF) before quoting it.